Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors with Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033

IMPORTANCE: Initial results of this intergroup trial of imatinib for patients with metastatic/ unresectable GIST were reported in 2008 (http://www.ncbi.nlm.nih.gov/pubmed/18235122). Updated results reported here show long-term survival with a significant subset of patients surviving 10 or more years...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA Oncol
Hauptverfasser: Heinrich, Michael C., Rankin, Cathryn, Blanke, Charles D., Demetri, George D., Borden, Ernest C., Ryan, Christopher W., von Mehren, Margaret, Blackstein, Martin E., Priebat, Dennis A., Tap, William D., Maki, Robert G., Corless, Christopher L., Fletcher, Jonathan A., Owzar, Kouros, Crowley, John J., Benjamin, Robert S., Baker, Laurence H.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727908/
https://ncbi.nlm.nih.gov/pubmed/28196207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.6728
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge